Patent Extensions’ Cost To Be Evaluated By FDA Under Ag Approps Request

FDA will report on the costs to consumers of drug patent extensions by March

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet